Rockwell Medical, Inc. provided earnings guidance for the full year 2022. For the year, the company anticipated revenue of $65 million to $70 million, which represents up to a 13% increase over revenue in 2021.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.85 USD | +0.27% |
|
-2.37% | -2.12% |
May. 30 | Rockwell Medical, Inc. Promotes Tim Chole to Chief Commercial Officer | CI |
May. 14 | Transcript : Rockwell Medical, Inc., Q1 2024 Earnings Call, May 14, 2024 |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-2.12% | 56.08M | |
+52.93% | 803B | |
+40.98% | 629B | |
-7.08% | 351B | |
+17.40% | 324B | |
+10.58% | 303B | |
+16.42% | 244B | |
+2.17% | 226B | |
+10.66% | 215B | |
+6.24% | 164B |
- Stock Market
- Equities
- RMTI Stock
- News Rockwell Medical, Inc.
- Rockwell Medical, Inc. Provides Earnings Guidance for the Full Year 2022